About Adze

Oncolytic Immunotherapies

Adze Biotechnology is a pre-clinical stage company developing systemically deliverable oncolytic immunotherapies for the treatment of cancers with significant unmet needs.

Adze Biotechnology has exclusive licenses to oncolytic immunotherapies developed in the lab of Dr Michael Barry of Mayo Clinic.